Smith & Nephew Plc Director/PDMR Shareholding (0005T)
09 Novembre 2023 - 6:03PM
UK Regulatory
TIDMSN.
RNS Number : 0005T
Smith & Nephew Plc
09 November 2023
SMITH & NEPHEW PLC
9 November 2023
NOTIFICATION AND PUBLIC DISCLOSURE IN ACCORDANCE WITH THE
REQUIREMENTS OF THE EU MARKET ABUSE REGULATION OF TRANSACTIONS BY
PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES ("PDMR") AND
PERSONS CLOSELY ASSOCIATED WITH THEM.
On 8 November 2023, Smith & Nephew plc (the "Company")
received notification of the following transactions as detailed
below.
Reason for the notification
Initial notification Initial notification
/Amendment
--------------------------------------------------
Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
Name Smith & Nephew plc
--------------------------------------------------
LEI 213800ZTMDN8S67S1H61
--------------------------------------------------
Details of the transaction(s): section to be repeated for (i)
each type of instrument; (ii) each type of transaction; (iii)
each date; and (iv) each place where transactions have been conducted
Description of the Smith & Nephew plc SPON ADR American Depositary
financial instrument, Shares (ADS)
type of instrument
--------------------------------------------------
Identification code ISIN: US83175M2052
--------------------------------------------------
Nature of the transaction PDMR is a participant of the Company's Employee
Stock Purchase Plan, which purchased American
Depository Shares through the Company's Dividend
Re-Investment Plan following the 2023 interim
dividend payment on 1 November 2023.
--------------------------------------------------
Date of Transaction 2023-11-3
--------------------------------------------------
Place of Transaction New York Stock Exchange
--------------------------------------------------
Director Price
Name / PDMR ($) Volume Aggregated information
Bradley Cannon
(President, Global
Orthopaedics) PDMR 24.1701 47.24805 N/A Single Transaction
---------- -------- --------- -----------------------
Alison Parkes
(Chief Compliance
Officer) PDMR 24.1701 12.13441 N/A Single Transaction
---------- -------- --------- -----------------------
Mizanu Kebede
(Chief Quality
& Regulatory
Affairs Officer) PDMR 24.1701 10.49685 N/A Single Transaction
---------- -------- --------- -----------------------
Deepak Nath
(Chief Executive
Officer) Director 24.1701 10.4803 N/A Single Transaction
---------- -------- --------- -----------------------
Paul Connolly
(President, Global
Operations) PDMR 24.1701 7.86095 N/A Single Transaction
---------- -------- --------- -----------------------
Scott Schaffner
(President, Sports
Medicine) PDMR 24.1701 25.00279 N/A Single Transaction
---------- -------- --------- -----------------------
Sarah Carne
Deputy Company Secretary
Smith & Nephew plc
Tel: +44 (0)1923 477100
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
DSHFLFIDLFLAIIV
(END) Dow Jones Newswires
November 09, 2023 12:03 ET (17:03 GMT)
Grafico Azioni Smith & Nephew (LSE:SN.)
Storico
Da Apr 2024 a Mag 2024
Grafico Azioni Smith & Nephew (LSE:SN.)
Storico
Da Mag 2023 a Mag 2024